Modulation of the N13 component of the somatosensory evoked potentials in an experimental model of central sensitization in humans.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 10 2021
Historique:
received: 30 03 2021
accepted: 01 10 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 29 1 2022
Statut: epublish

Résumé

The N13 component of somatosensory evoked potential (N13 SEP) represents the segmental response of dorsal horn neurons. In this neurophysiological study, we aimed to verify whether N13 SEP might reflect excitability changes of dorsal horn neurons during central sensitization. In 22 healthy participants, we investigated how central sensitization induced by application of topical capsaicin to the ulnar nerve territory of the hand dorsum modulated N13 SEP elicited by ulnar nerve stimulation. Using a double-blind placebo-controlled crossover design, we also tested whether pregabalin, an analgesic drug with proven efficacy on the dorsal horn, influenced capsaicin-induced N13 SEP modulation. Topical application of capsaicin produced an area of secondary mechanical hyperalgesia, a sign of central sensitization, and increased the N13 SEP amplitude but not the peripheral N9 nor the cortical N20-P25 amplitude. This increase in N13 SEP amplitude paralleled the mechanical hyperalgesia and persisted for 120 min. Pregabalin prevented the N13 SEP modulation associated with capsaicin-induced central sensitization, whereas capsaicin application still increased N13 SEP amplitude in the placebo treatment session. Our neurophysiological study showed that capsaicin application specifically modulates N13 SEP and that this modulation is prevented by pregabalin, thus suggesting that N13 SEP may reflect changes in dorsal horn excitability and represent a useful biomarker of central sensitization in human studies.

Identifiants

pubmed: 34675309
doi: 10.1038/s41598-021-00313-7
pii: 10.1038/s41598-021-00313-7
pmc: PMC8531029
doi:

Substances chimiques

Sensory System Agents 0
Capsaicin S07O44R1ZM

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20838

Informations de copyright

© 2021. The Author(s).

Références

J Neurophysiol. 2006 Dec;96(6):3551-5
pubmed: 17021023
Am J Physiol. 1983 Dec;245(6):R751-4
pubmed: 6660319
Brain. 1984 Dec;107 ( Pt 4):1179-88
pubmed: 6509313
J Neurophysiol. 1998 Dec;80(6):2801-10
pubmed: 9862885
Nature. 1983 Dec 15-21;306(5944):686-8
pubmed: 6656869
Anesthesiology. 2002 Jul;97(1):102-7
pubmed: 12131110
Arthritis Res Ther. 2015 Oct 28;17:303
pubmed: 26510702
J Clin Neurophysiol. 1998 May;15(3):227-34
pubmed: 9681560
J Neurophysiol. 1993 Mar;69(3):703-16
pubmed: 8385190
Pain. 2008 Jul 31;137(3):473-477
pubmed: 18583048
Pain. 2003 Sep;105(1-2):285-91
pubmed: 14499446
Ann Neurol. 1981 Jun;9(6):607-11
pubmed: 7259124
Eur J Pain. 2021 Aug;25(7):1389-1428
pubmed: 33759294
Br J Anaesth. 2005 Oct;95(4):518-23
pubmed: 16113037
Electroencephalogr Clin Neurophysiol. 1990 Jan-Feb;77(1):28-38
pubmed: 1688782
J Neurophysiol. 2015 Nov;114(5):2672-81
pubmed: 26334010
Clin Pharmacokinet. 2010 Oct;49(10):661-9
pubmed: 20818832
Neurol Sci. 2019 Jul;40(7):1425-1431
pubmed: 30941628
J Pain. 2010 Dec;11(12):1241-9
pubmed: 20472509
J Neurophysiol. 1991 Jul;66(1):228-46
pubmed: 1919669
Brain. 1991 Feb;114 ( Pt 1B):361-79
pubmed: 2004247
Electroencephalogr Clin Neurophysiol. 1981 Oct;52(4):257-75
pubmed: 6169503
J Neurophysiol. 2016 Nov 1;116(5):2210-2220
pubmed: 27535371
Eur J Pain. 2020 Nov;24(10):2015-2026
pubmed: 32794307
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18195-200
pubmed: 16330766
J Neurophysiol. 1997 Oct;78(4):1973-82
pubmed: 9325365
Brain Res Brain Res Rev. 2002 Oct;40(1-3):29-44
pubmed: 12589904
Clin Neurophysiol. 2008 Aug;119(8):1705-1719
pubmed: 18486546
J Neurophysiol. 2014 Apr;111(8):1564-73
pubmed: 24453277
Pain. 1992 Nov;51(2):207-219
pubmed: 1484717
Anesthesiology. 2016 Nov;125(5):846-849
pubmed: 27575448
J Neurophysiol. 1991 Jul;66(1):190-211
pubmed: 1919666
Prog Neurobiol. 1992;38(4):397-421
pubmed: 1574584
J Neurophysiol. 2013 Sep;110(5):1107-16
pubmed: 23678019
J Pain. 2021 May;22(5):487-497
pubmed: 33166655
Acta Physiol Scand. 1995 Sep;155(1):87-97
pubmed: 8553881
Clin Neurophysiol. 2017 Aug;128(8):1445-1456
pubmed: 28618295
Pain. 2011 Jul;152(7):1532-1539
pubmed: 21440369
J Clin Neurosci. 2019 Jul;65:17-22
pubmed: 31080004
Pain Med. 2020 Apr 1;21(4):736-746
pubmed: 31216028
Pain. 2008 Dec;140(3):456-464
pubmed: 19004552
Pain. 2016 Aug;157(8):1682-1695
pubmed: 27023419
J Neurosci. 2000 Dec 15;20(24):9277-83
pubmed: 11125006
Pain. 1993 Apr;53(1):43-51
pubmed: 8316389

Auteurs

A Di Lionardo (A)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

G Di Stefano (G)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

C Leone (C)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

G Di Pietro (G)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

E Sgro (E)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

E Malara (E)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

C Cosentino (C)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.

C Mollica (C)

Department of Statistical Sciences, Sapienza University, Rome, Italy.

A J Blockeel (AJ)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.

O Caspani (O)

Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

L Garcia-Larrea (L)

Lyon Neurosciences Center Research Unit Inserm U 1028, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.
Pain Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.

A Mouraux (A)

UCLouvain, Institute of Neuroscience (IoNS), Brussels, Belgium.

R D Treede (RD)

Department of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

K G Phillips (KG)

Neuroscience Next Generation Therapeutics, Eli Lilly and Company, Lilly Innovation Center, Cambridge, MA, 02142, USA.

M Valeriani (M)

Department of Neuroscience, Headache Center, Bambino Gesù Children's Hospital, Rome, Italy.
Center for Sensory-Motor Interaction, Aalborg University, Aalborg, Denmark.

Andrea Truini (A)

Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy. andrea.truini@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH